Putnam Investments’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$402K Buy
29,800
+8,305
+39% +$97.6K ﹤0.01% 998
2023
Q3
$276K Sell
21,495
-186
-0.9% -$3.35K ﹤0.01% 1085
2023
Q2
$392K Sell
21,681
-682
-3% -$12.7K ﹤0.01% 992
2023
Q1
$375K Sell
22,363
-956
-4% -$18.7K ﹤0.01% 1010
2022
Q4
$479K Buy
23,319
+7,191
+45% +$127K ﹤0.01% 936
2022
Q3
$309K Sell
16,128
-291
-2% -$6.54K ﹤0.01% 1074
2022
Q2
$386K Sell
16,419
-203
-1% -$5.81K ﹤0.01% 1006
2022
Q1
$544K Buy
16,622
+3,885
+31% +$125K ﹤0.01% 975
2021
Q4
$396K Buy
+12,737
New +$426K ﹤0.01% 1068

Other funds holding OFIX

Putnam Investments's OFIX Position: Q4 2023 in Review

Putnam Investments increased its Orthofix Medical (OFIX) stake by 39% in Q4 2023, buying an estimated $97.6K and bringing the position to 29,800 shares worth $402K. The position accounts for ﹤0.01% of the portfolio, ranked #998.

Putnam Investments first reported a position in OFIX in Q4 2021 and has held it in 9 quarters since. The position peaked at $544K in Q1 2022. 156 funds tracked by Wall St. Rank hold OFIX as of Q4 2023.

  • Putnam Investments held 29,800 shares of Orthofix Medical worth $402K as of Q4 2023.
  • Putnam Investments bought 8,305 Orthofix Medical shares in Q4 2023, an estimated $97.6K.
  • Orthofix Medical made up ﹤0.01% of Putnam Investments's portfolio in Q4 2023, its #998 holding.
  • Putnam Investments first reported a position in Orthofix Medical in Q4 2021 and has held it in 9 quarters since.
  • Putnam Investments's Orthofix Medical position peaked at $544K in Q1 2022.
  • 156 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.